Hadassah Medical Organization

This early-phase study is testing a new cell therapy called HBI0101 in people with multiple myeloma that has returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to better attack cancer cells. The main goals are to find th…

This study tests a custom-made cancer vaccine for people with metastatic melanoma, breast, lung, kidney, ovarian, colorectal, or stomach cancer. Lab-grown tumor cells are modified to trigger a stronger immune response, then killed and injected eight times over four months. The go…

This study compares a moderate-carbohydrate diet (120g carbs per day) to the standard high-carb diet (175g per day) in 120 pregnant women with diabetes who need insulin. The goal is to see if fewer carbs improve blood sugar control and pregnancy outcomes. Participants will follow…

This early-phase study tests a treatment where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells that carry a specific marker called NY-ESO-1. The therapy is given as a one-time infusion to adults with advanced or spreading cancers lik…

This study looks at whether a single dose of zoledronic acid can prevent bone loss that often happens when people start HIV medications. About 110 adults newly diagnosed with HIV will either receive the drug or just be monitored. Researchers will track bone density over four year…

This study tests whether watching relaxing virtual reality (VR) scenes before egg retrieval can lower pain in women freezing their eggs. One hundred women will be randomly assigned to either standard care or standard care plus a VR relaxation session. Pain levels will be measured…

This study tests whether a cannabis extract containing THC and CBD can reduce acute radicular back pain (nerve-related back pain) and the need for strong painkillers. About 200 adults with sudden back pain will receive either the cannabis oil or a placebo, and their pain and opio…

This early-stage study tests the safety and psychological effects of combining psilocybin (a psychedelic compound) with D-serine in 10 healthy adults aged 25-60. Participants receive one of two dose levels to see if D-serine can reduce the psychedelic experience. The goal is to g…